Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine

Biologic therapies for chronic rhinosinusitis with nasal polyps: a new paradigm

JPM, Free Full-Text

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study - Aikaterini Detoraki, Eugenio Tremante, Maria D'Amato, Cecilia Calabrese, Claudia

Mepolizumab reduces risk for repeat surgery for chronic rhinosinusitis with nasal polyps

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis - Fokkens - 2023 - Allergy - Wiley Online Library

Eosinophils & MOA NUCALA (mepolizumab) for CRSwNP

Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis - The Journal of Allergy and Clinical Immunology: In Practice

Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count - ScienceDirect

PDF) Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

Mepolizumab Induced Loss of Smell Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps From the SYNAPSE Study